Prescriptions in the PICU

Not yet recruiting

Brief Summary: STEP 1: IEC approval will be taken prior to the study. After the approval of the ethics committee, the study will commence.

STEP 2: Informed consent will be obtained from the parents of the study participants.

STEP 3: Data will be collected in the form of history as well as clinical examination, investigations will be recorded according to the format of the proforma designed for the study.

STEP 4: Each patient will be categorised into one out of four categories based on the antibiotic use in the patient.

1. Antibiotic indicated + prescribed

2. Antibiotic indicated + not prescribed

3. Antibiotic not indicated + prescribed

4. Antibiotic not indicated + not prescribed

The focus remains on categories 1 and 4, to study the common indications of antibiotic use at our PICU. We don not expect many patients to fall under categories 2 and 3 due to our vigilant patient care. However, it is important to include them in case of special circumstances.

STEP 5: Once an antibiotic has been prescribed, relevant details such as the dose, route, duration of therapy will be documented.

STEP 6: Further the plan on review of antibiotic therapy will be followed. On review, the change in plan of antibiotic use will be categorised as one of the following: Change the dose, Change the route, Stop antibiotic, Continue same treatment.

Recruitment & Eligibility

Inclusion Criteria

All patients admitted in the PICU.

Exclusion Criteria

Patients/ parents denying consent Pediatric oncology patients.

Primary Outcome Measures

Name	Time	Method
TO STUDY INDICATIONS FOR PRESCRIPTIONS IN THE PICU	Day 1

Secondary Outcome Measures

Name	Time	Method
To study antibiotic review with respect to dose modifications/ change in antibiotic/ change in route of administration during the course of treatment in the PICU	3 days
To study factors determining the decision to stop antibiotics in patients admitted in the PICU	5 days

Locations (1): PICU, KMC Manipal
🇮🇳
Udupi, KARNATAKA, India
PICU, KMC Manipal
🇮🇳Udupi, KARNATAKA, India
Dr Asma Javed
Principal investigator
9890893697
dr.asmajaved20@gmail.com